tirzepatide and mdma YELLOW community notice published by @cantestcbr 14 November 2025 👇 High Dose Pill ➖➖➖➖➖ A GREY 'MASERATI' PRESS PILL was brought to CanTEST for testing, expected to contain MDMA. The sample Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Industry forecasts project a compound annual growth rate (CAGR) of 12.4% from 2024 to 2030 , with the market size expected to exceed $18.7 billion by 2030

A randomized controlled trial was carried out to examine the effectiveness of once-weekly subcutaneous semaglutide 2.4 mg as an addition to intensive behavioral therapy and initial low-calorie diet in individuals with overweight or obesity

More power, more complexity, more unknowns

Others will find it less expensive and easier to access weight loss medications through their primary care physicians

SILICON DIOXIDE (TRACE, OW AGENT)

Not enough time in a 15-minute consultation to cover what patients actually need to succeed with their treatment